Join our FREE personalized newsletter for news, trends, and insights that matter to everyone in America

Newsletter
New

American Regent Recalls Adequan Injections For Dogs And Horses

Card image cap

Editor’s note: When a company announces a recall, market withdrawal or safety alert, the FDA posts the company’s announcement as a public service. PETS+ shares this information with our readership.

American Regent, Inc. Animal Health is recalling two lots of Adequan Canine Injection and two lots of Adequan i.m. Injection for horses after glass fibers were discovered during testing of retained samples. Both are prescription joint therapy medications administered by or under the direction of a licensed veterinarian. No adverse events related to the recalled lots have been reported to date.

Advertisement

The announcement reads in its entirety:

SHIRLEY, N.Y., July 31, 2026 /PRNewswire/ — American Regent, Inc. Animal Health is conducting a nationwide recall of two lots (25011 and 3369) of Adequan® Canine Injection (for dogs), 100 mg/mL 5 mL multi-dose vials and two lots (24416 and 25265P) of Adequan® i.m. Injection (for horses), 500 mg/5 mL single-dose 5 mL vials to the consumer level. The products are being recalled due to the presence of glass fibers found during testing of internally retained samples.

Risk Statement: The administration of an intramuscular injectable product containing particulate matter, such as glass fibers, may result in local irritation, swelling, inflammation, injection site pain, infection, or abscesses. To date, American Regent, Inc. has not received any reports of adverse events related to the recalled lots.

Both Adequan Canine and Adequan i.m. are clear, colorless to slightly yellow solutions. The products are for intramuscular injections and are to be used by or under the direction of a licensed veterinarian.

Adequan Canine is a prescription medication used in the treatment of non-infectious degenerative or traumatic joint dysfunction in dogs.

Adequan i.m. is a prescription medication used in the treatment of noninfectious degenerative or traumatic joint dysfunction and associated lameness in horses.

Adequan Canine Lot #’s 3369 and 25011 were distributed nationwide to online pharmacies, distributors/ wholesalers and veterinarians in the United States on 05/22/2024 and 04/14/2025 respectively and Adequan i.m. Lot #’s 24416 and 25265P were distributed nationwide to online pharmacies, distributors/ wholesalers and veterinarians in the United States on 05/08/2025 and 01/22/2026 respectively.

Any person or entity with the recalled product lots should not use the products.

Consumers: Stop using the recalled products lots. Contact your veterinarian if your pets have experienced any problems that may be related to using the recalled products.

Distributors and retailers: Stop distribution, return any leftover recalled product to the manufacturer, or discard.

Veterinary hospitals, clinics, and other consignees: Return any unused product to the manufacturer or discard.

CONTACT AMERICAN REGENT INC.

Consumers and veterinary professionals with questions regarding this recall can contact American Regent Inc. using the below information.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA at 1-888-FDA-VETS or online at http://www.FDA.gov/reportanimalae.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

American Regent, Inc. is committed to the safety of patients who rely on its products and is taking this precautionary action to protect public health.

SOURCE American Regent, Inc.